CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $958,802 | +242.3% | 64,306 | +151.4% | 0.00% | – |
| Q2 2023 | $280,090 | -81.4% | 25,579 | -85.2% | 0.00% | -100.0% |
| Q1 2023 | $1,506,066 | +45999.4% | 172,714 | +33050.5% | 0.00% | – |
| Q4 2022 | $3,267 | -18.3% | 521 | +52000.0% | 0.00% | – |
| Q3 2022 | $4,000 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2022 | $29,462,000 | -5.2% | 9,987 | -0.1% | 0.00% | – |
| Q1 2022 | $31,088,000 | -92.6% | 9,996 | -92.0% | 0.00% | -100.0% |
| Q4 2021 | $421,821,000 | +732.4% | 124,799 | +798.9% | 0.00% | – |
| Q3 2021 | $50,677,000 | +67.3% | 13,884 | +99.9% | 0.00% | – |
| Q2 2021 | $30,285,000 | -76.9% | 6,946 | -75.9% | 0.00% | – |
| Q1 2021 | $130,866,000 | +77.1% | 28,825 | +123.8% | 0.00% | – |
| Q4 2020 | $73,914,000 | -51.1% | 12,877 | -38.3% | 0.00% | – |
| Q3 2020 | $151,070,000 | +475.2% | 20,866 | +177.3% | 0.00% | – |
| Q2 2020 | $26,266,000 | -29.0% | 7,526 | -69.9% | 0.00% | – |
| Q1 2020 | $37,018,000 | +138.1% | 25,012 | +215.3% | 0.00% | – |
| Q4 2019 | $15,549,000 | -69.4% | 7,933 | -20.1% | 0.00% | – |
| Q3 2019 | $50,857,000 | +6.2% | 9,933 | +48.5% | 0.00% | – |
| Q2 2019 | $47,879,000 | -71.0% | 6,687 | -46.2% | 0.00% | – |
| Q1 2019 | $165,124,000 | +673.4% | 12,434 | +545.3% | 0.00% | – |
| Q3 2018 | $21,351,000 | -17.4% | 1,927 | 0.0% | 0.00% | – |
| Q2 2018 | $25,860,000 | -75.8% | 1,927 | -96.5% | 0.00% | – |
| Q3 2015 | $106,700,000 | -11.9% | 55,000 | +22.2% | 0.00% | – |
| Q2 2015 | $121,050,000 | -12.5% | 45,000 | +125.0% | 0.00% | – |
| Q1 2015 | $138,400,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |